Clostridium infectious disease
MONDO:0024388Infections with bacteria of the genus clostridium.
Also known as: Clostridium infection, commensal Clostridium infection, commensal infection, Clostridium, commensal infections, Clostridium, infection, Clostridium, infections, Clostridium
97 clinical trials for this condition and its sub-types, 48 tagged with Clostridium infectious disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Clostridium infectious disease
-
Tetanus 44 trials
1 sub-type
- Tetanus neonatorum 0 trials
-
Botulism 5 trials
4 sub-types
- Foodborne botulism 0 trials
- Iatrogenic botulism 0 trials
- Inhalational botulism 0 trials
- Toxin-mediated infectious botulism 0 trials Sub-types →
-
1 sub-type
- Gas gangrene 0 trials
Most studied deeper sub-types
-
Engineered yeast pill takes on superbug c. diff in first human trial
Disease control Not yet recruitingThis early-stage trial tests an oral capsule containing a genetically modified probiotic yeast designed to neutralize toxins produced by C. diff bacteria. The study first evaluates safety in healthy adults, then in people at risk for recurrent C. diff infection. Participants take…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a potato starch shake off Drug-Resistant gut bacteria?
Disease control Not yet recruitingThis trial tests whether a dietary fiber called resistant potato starch can reduce the amount of drug-resistant bacteria living in the gut. The study enrolls Veterans who carry these bacteria without symptoms, and half will take the starch daily while the other half takes a place…
Phase 2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Could a sweetener beat a gut infection? new trial explores xylitol for c. diff in IBD
Disease control Not yet recruitingThis study tests if xylitol, a common sweetener, can safely clear C. difficile bacteria from the gut in people with inflammatory bowel disease (IBD). About 99 adults with mild or inactive IBD will take either a low or high dose of xylitol or a placebo for four weeks. Researchers …
Phase 1 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could a sweetener beat a gut infection? early trial tests xylitol for c. diff in IBD patients
Disease control Not yet recruitingThis pilot study tests whether xylitol, a common sugar alcohol, can safely clear C. difficile bacteria from the guts of people with inflammatory bowel disease (IBD). About 69 adults with mild or inactive IBD will take different doses of xylitol for up to 8 weeks. Researchers will…
Early phase 1 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New hope for IBD patients: can a better antibiotic stop c. diff for good?
Disease control Not yet recruitingThis study compares two antibiotics, fidaxomicin and vancomycin, to see which one is better at clearing C. difficile bacteria from the gut in people with inflammatory bowel disease (IBD). About 60 adults with IBD will take one of the two antibiotics for 10 days and be followed fo…
Phase 4 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Bile acid breakthrough: could a Decades-Old pill stop c. diff in its tracks?
Prevention Not yet recruitingThis early-phase trial tests whether adding Ursodeoxycholic Acid (UDCA) to standard antibiotics can prevent Clostridioides difficile (C. diff) infection from returning. About 30 adults with C. diff and risk factors for recurrence will take UDCA three times daily for up to eight w…
Early phase 1 • Sponsor: Medical College of Wisconsin • Aim: Prevention
Last updated Jun 27, 2026 12:25 UTC
-
Gut bacteria may help pancreatic surgery recovery
Symptom relief Not yet recruitingThis study tests whether a probiotic called Clostridium butyricum CBM588 can reduce diarrhea and improve quality of life in people who have had their pancreas removed due to cancer or other growths. About 158 patients will take either the probiotic or a placebo for three months a…
Sponsor: Casa di Cura Dott. Pederzoli • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
FMT vs antibiotics: which works better Long-Term for c. diff?
Knowledge-focused Not yet recruitingThis study looks at adults who had a C. diff infection and were treated with either a fecal transplant (FMT) or antibiotics alone. Researchers want to see if FMT leads to healthier gut bacteria and fewer health problems years later. Participants will give blood, stool, and urine …
Sponsor: Umeå University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC